All In MedTech

Device Trial Radar · NCT03169751

An Exploratory Trial Using sEMG to Differentiate PNES From Epileptic Seizures

Last checked: Nov 20, 2026Latest source record: Dec 20, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

71

Actual

Start

Sep 1, 2017

Primary completion

Feb 1, 2020

Study completion Feb 1, 2020

Sponsor

Lead sponsor
Brain SentinelAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 30, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an observational study of subjects receiving standard of care therapy, while admitted to Epilepsy Monitoring Unit, Department of Neurology, General Hospital Hietzing with Neurological Center Rosenhügel. Additional monitoring provided by the SPEAC System will be compared to the gold standard, vEEG. The SPEAC System is being evaluated while being used in adjunct to standard of care.

Conditions

  • Non-Epileptic Seizure
  • Motor Seizure
  • Epilepsy

Interventions

  • Brain Sentinel Monitoring and Alerting SystemDevice

    The Brain Sentinel Monitoring and Alerting System is indicated for use as an adjunct to seizure monitoring in adults in the home or healthcare facilities during periods of rest. The device is to be used on the belly of the biceps muscle to analyze surface electromyographs (sEMG) signals that may be associated with generalized tonic-clonic (GTC) seizures and to provide an alarm to alert caregivers of unilateral, appendicular, tonic extension that could be associated with a GTC seizure. The System records and stores sEMG data for subsequent review by a trained healthcare professional.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 3 independent physicians' abilities to differentiate between epileptic events (with upper extremity motor involvement) and PNES (with upper extremity motor involvement) using vEEG, using a majority rules approach (2 out of 3)Time frame: 5 days
  2. 3 independent physicians' abilities to differentiate between epileptic events (with upper extremity motor involvement) and PNES (with upper extremity motor involvement) using sEMG, using a majority rules approach (2 out of 3)Time frame: 5 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Krankenhaus Hietzing mit Neurologischem Zentrum Rosenhugel

    Vienna, Austria

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.